Abstract：Objective To explore the effects of Hengqing Ⅱ Prescribtion combined with Donepezil Hydrochloride on patients with Alzheimer’s disease (AD) and its mechanism. Methods A total of 107 AD patients admitted to Shanghai Jiao Tong University Affiliated Sixth People’s Hospital from January 2018 to January 2019 were randomly divided into control group（53 cases） and treatment group（54 cases） according to the random number table method. Both groups were given routine therapy. The control group was given Donepezil Hydrochloride Tablets on the basis of conventional treatment, and the treatment group was given Hengqing Ⅱ Prescribtion and Donepezil Hydrochloride Tablets on the basis of conventional treatment. The treatment course of both groups was three months. The cognitive scores of AD asesment scale-cognitive section (ADAS-Cog), activities of daily living (ADL), the montreal cognitive assessment scale (MoCA), neuropsychiatric inventory (NPI) and mini-mentalstateexamination (MMSE) were recorded before and after treatment. The levels of serum Aβ precursor protein (APP), Aβ1-42, homocysteine (Hcy), interleukin-1 (IL-1), IL-6 and IL-10 were measured. Adverse reactions were recorded. Results The scores of ADAs-cog and NPI of both groups after treatment were lower than before treatment, the scores of ADL, MoCA and MMSE were higher than those before treatment, the levels of serum APP, Aβ1-42, Cys C, Hcy, IL-1, IL-6 and IL-10 were all lower than those before treatment, the differences were statistically significant (P ＜ 0.05 or P ＜ 0.01). After treatment, the scores of ADAs-cog and NPI of the treatment group were lower than those in the control group, the scores of ADL, MoCA and MMSE were higher than those in the control group, and the levels of APP, Aβ1-42, Cys C, Hcy, IL-1, IL-6 and IL-10 were lower than those in the control group the differences were statistically significant (all P ＜ 0.05). There was no significant difference in the total adverse reaction rate between the two groups (P ＞ 0.05). Conclusion Hengqing Ⅱ Prescribtion combined with Donepezil Hydrochloride can significantly improve cognitive function of AD patients, which was exerted by decreasing the levels of serum APP, Aβ1-42, Cys C, Hcy, IL- 1, IL- 6 and IL-10 of AD patients.
孟胜喜. 恒清Ⅱ号方联合盐酸多奈哌齐对阿尔茨海默病患者的疗效及其作用机制[J]. 中国医药导报, 2021, 18(3): 140-144.
MENG Shengxi. Effects of Hengqing Ⅱ Prescribtion and Donepezil Hydrochloride on patients with Alzheimer’s disease and its mechanism. 中国医药导报, 2021, 18(3): 140-144.
[1] Scheltens P，Blennow K，Breteler MM，et al. Alzheimer’s disease [J]. Lancet，2016，388（10043）：505-517.
[2] Meng SX，Wang B，Li WT. Intermittent hypoxia improves cognition and reduces anxiety-related behavior in APP/PS1 mice [J]. Brain Behav，2020，10（2）：e01513.
[3] Landau SM，Horng A，Fero A，et al. Amyloid negativity in patients with clinically diagnosed Alzheimer disease and MCI [J]. Neurology，2016，86（15）：1377-1385.
[4] 孟胜喜，霍清萍，王兵，等.恒清Ⅱ号方联合盐酸多奈哌齐治疗阿尔茨海默病疗效观察[J].现代中西医结合杂志，2020，29（3）：234-238，273.
[5] Mc Khann GM，Knopman DS，Chertkow H，et al. The diagnosis of dementia due to Alzheimer’s disease：recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease [J]. Alzheimer Dement，2011， 7（3）：263-269.
[6] Zainal NH，Silva E，Lim LL，et al. Psychometric properties of Alzheimer’s disease assessment scale-cognitive subscale for mild cognitive impairment and mild Alzheimer’s disease patients in an Asian context [J]. Ann Acad Med Singapore，2016，45（7）：273-283.
[7] Ben Jemaa S，Attia Romdhane N，Bahri-Mrabet A，et al. Anarabic version of the cognitive subscale of the Alzheimer’s disease assessment scale （ADAS-Cog）：reliability，validity，and normative data [J]. J Alzhimers Dis，2017，60（1）：11-21.
[8] 于焰，张娜，娄毅，等.蒙特利尔认知评估量表在老老年认知功能评估中的应用[J].中华老年心脑血管病杂志，2011，13（4）：295-298.
[9] Trevizan FB，Miyazaki MCOS，Silva YLW，et al. Quality of life，depression，anxiety and coping strategies after heart transplantation [J]. Braz J Cardiov Surg，2017，32（3）：162-170.
[10] Bulboac AE，Bolboac SD，Bulboac AC，et al. Association between low thyroid-stimulating hormone，posterior cortical atrophy and nitro-oxidative stress in elderly patients with cognitive dysfunction [J]. Arch Med Sci 2017，13（5）：1160-1167.
[11] Guan S，Bao YM，Jiang B，et al. Protective effect of protocatechuic acid from Alpinia oxyphylla on hydrogen peroxide-induced oxidative PC12 cell death [J]. Eur J Pharmacol，2006，538（1/3）：73-79.
[12] Liu X，Zhang J，Wang S，et al. Astragaloside IV attenuates the H2O2-induced apoptosis of neuronal cells by inhibiting alpha-synuclein expression via the p38 MAPK pathway [J]. Int J Mol Med，2017，40（6）：1772-1780.
[13] 刘海云，纪玉龙，何志坚.菟丝子提取物对自然衰老小鼠学习记忆能力及肝和脑组织ATP酶活力的影响[J].中国老年学杂志，2018，38（23）：5794-5796.
[14] Yang LC，Li J，Xu SF，et al. L-3-n-butylphthalide promotes neurogenesis and neuroplasticity in cerebral ischemic rats [J]. CNS Neurosci Ther，2015，21（9）：733.
[15] Huang Y，Jiang C，Hu Y，et al. Immunoenhancement effect of rehmannia glutinosa polysaccharide on lymphocyte proliferation and dendritic cell [J]. Carbohydr Polym，2013，96（2）：516-521.
[16] Jin BW，J Lee，Min RE，et al. The Effects of Loranthus parasiticus on Scopolamine-Induced Memory Impairment in Mice [J]. Evid Based Complement Alternat Med，2014， 2014：860180.
[17] 张婉虹，谢华.牡蛎肉水提液延缓去卵巢大鼠脑衰老的作用[J].中国老年学杂志，2007，27（7）：1240.
[18] Hu W，Wang G，Li P，et al. Neuroprotective effects of macranthoin G from Eucommia ulmoides against hydrogen peroxide-induced apoptosis in PC12 cells via inhibiting NF-κB activation [J]. Chem Biol Interact，2014， 224（13）：108-116.
[19] 杨明，杨虹，陈锦香.地龙提取液对兔急性脑缺血再灌流损伤的保护作用[J].吉林医学，2011，32（19）：3847-3848.
[20] Xia Q，Wang X，Xu D，et al. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential Oil [J]. Thrombosis Research，2012，130（3）：409-414.
[21] Liu Z，Wang W，Feng N，et al. Parishin C’s prevention of Abeta 1-42-induced inhibition of long-term potentiation is related to NMDA receptors [J]. Acta Pharmaceutica Sinica B，2016，6（3）：189-197.
[22] Xian YF，Mao QQ，Wu JC，et al. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation [J]. J Alzheimers Dis，2014， 39（2）：331-346.
[23] Blennow K，de Leon MJ，Zetterberg H. Alzheimer’s disease [J]. Lancet，2006，368（9533）：387-403.
[24] 温世荣，于艳红，王德生，等.凋亡相关蛋白在阿尔茨海默病病理改变中的作用[J].中国医药导报，2019，16（25）：16-19.
[25] 徐哲，夏青春.阿尔茨海默病精神行为症状与HCY水平及颈动脉粥样硬化的关系探讨[J].中国现代医生，2019， 57（35）：4-7.
[26] Zheng H，Koo EH. Biology and pathophysiology of the amyloid precursor protein [J]. Mol Neurodegener，2011，6（1）：27.
[27] Perlenfein TJ，Mehlhoff JD，Murphy RM. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid [J]. J Biol Chem，2017，292（27）：11485-11498.
[28] Holford P. The prevention of memory loss and progression to alzheimer’s disease with B vitamins，antioxidants and essential fatty acids：a review of the evidence [J]. J Ortho Med，2011，26（2）：53-58.
2021, Vol. 18 
京公网安备 11010502046598号